US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist

10.1300
+0.4800+4.97%

Close Nov 22 16:00 ET

106.00MMarket Cap0.11P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-68.62%-11.53M

-47.68%-16.28M

38.30%-6.2M

-14.69%-30.68M

29.80%-2.77M

-219.39%-6.84M

11.58%-11.03M

37.44%-10.05M

62.27%-26.75M

76.96%-3.94M

Net income from continuing operations

540.65%23.04M

1,301.79%98.46M

-1,118.38%-121.29M

24.28%-31.54M

16.75%-8.17M

-263.78%-5.23M

36.91%-8.19M

54.85%-9.96M

50.63%-41.66M

48.89%-9.81M

Operating gains losses

-34,825.00%-34.93M

-69,425.00%-27.73M

-33.33%120K

-87.65%720K

--600K

---100K

--40K

--180K

--5.83M

----

Depreciation and amortization

-17.07%34K

-19.51%33K

3.03%34K

-4.82%158K

22.86%43K

20.59%41K

36.67%41K

-50.75%33K

-89.98%166K

-88.14%35K

Deferred tax

-275.00%-14K

0.00%7K

-12.50%7K

-50.00%14K

-212.50%-9K

60.00%8K

16.67%7K

-11.11%8K

27.27%28K

144.44%8K

Other non cash items

--0

-24,799.43%-86.2M

32,917.43%115.56M

31.61%1.83M

--0

218.93%1.13M

3.87%349K

0.00%350K

74.94%1.39M

0.00%349K

Change In working capital

58.59%-1.51M

68.15%-1.33M

17.07%-1.26M

-15,300.00%-9.24M

144.04%85K

-358.09%-3.64M

-173.34%-4.16M

-719.11%-1.52M

-102.11%-60K

54.16%-193K

-Change in receivables

35.41%-965K

-99.75%2K

-90.49%101K

-38.09%1.78M

331.74%1.4M

-378.73%-1.49M

52.82%813K

-56.06%1.06M

795.65%2.88M

31.79%-605K

-Change in inventory

--0

11.11%20K

--0

1,700.00%18K

-50.00%1K

-92.31%1K

151.43%18K

109.09%2K

-Change in prepaid assets

-518.46%-816K

-392.28%-1.44M

54.30%-154K

-58.69%447K

156.40%97K

-74.58%195K

-38.27%492K

-8.71%-337K

277.00%1.08M

82.18%-172K

-Change in payables and accrued expense

112.42%301K

102.47%136K

47.65%-1.18M

-178.81%-11.48M

-237.49%-1.3M

-648.15%-2.42M

-93.46%-5.5M

-18.90%-2.26M

-201.80%-4.12M

111.38%947K

-Change in other current liabilities

463.64%80K

247.06%25K

-1,330.77%-186K

-744.44%-76K

-118.18%-24K

-83.33%-22K

-54.55%-17K

-152.00%-13K

80.00%-9K

-320.00%-11K

-Change in other working capital

----

-206.25%-51K

618.18%158K

-20.45%70K

75.14%-88K

--88K

--48K

--22K

--88K

---354K

Cash from discontinued investing activities

Operating cash flow

-68.62%-11.53M

-47.68%-16.28M

38.30%-6.2M

-14.69%-30.68M

29.80%-2.77M

-219.39%-6.84M

11.58%-11.03M

37.44%-10.05M

62.27%-26.75M

76.96%-3.94M

Investing cash flow

Cash flow from continuing investing activities

367.67%356K

-40.00%-133K

-133K

15.93%-95K

Net PPE purchase and sale

--0

126.32%25K

--0

--25K

15.93%-95K

--0

Net business purchase and sale

--0

--356K

----

--0

----

Net other investing changes

----

---158K

--0

---158K

----

Cash from discontinued investing activities

Investing cash flow

--0

367.67%356K

-40.00%-133K

--0

---133K

15.93%-95K

--0

Financing cash flow

Cash flow from continuing financing activities

-178.93%-472K

690.02%108.61M

270.37%25.04M

-98.78%1K

10.7M

104.05%598K

13.75M

-113.77%-14.7M

7.89%82K

Net issuance payments of debt

--0

----

---21.24M

--0

---15.24M

----

--0

--14.81M

Net common stock issuance

--0

741.03%115.63M

412.88%46.22M

100.01%1K

--25.94M

--6.53M

--13.75M

-120.54%-14.77M

-17,914.63%-14.77M

Proceeds from stock option exercised by employees

--0

----

-8.22%67K

--0

----

-96.22%73K

-69.62%48K

Net other financing activities

--0

---472K

---7.01M

----

Cash from discontinued financing activities

Financing cash flow

--0

-178.93%-472K

690.02%108.61M

270.37%25.04M

-98.78%1K

--10.7M

104.05%598K

--13.75M

-113.77%-14.7M

7.89%82K

Net cash flow

Beginning cash position

1,349.82%93.56M

553.47%110.31M

-43.34%7.55M

-75.72%13.32M

-39.97%10.31M

-43.84%6.45M

-56.49%16.88M

-75.72%13.32M

187.15%54.86M

-76.11%17.18M

Current changes in cash

-398.70%-11.53M

-60.67%-16.76M

2,784.25%102.77M

86.11%-5.77M

28.33%-2.77M

-32.14%3.86M

61.81%-10.43M

122.18%3.56M

-216.19%-41.55M

77.35%-3.86M

End cash Position

695.48%82.03M

1,349.82%93.56M

553.47%110.31M

-43.33%7.55M

-39.97%10.31M

-43.84%6.45M

-56.49%16.88M

-75.72%13.32M

Free cash flow

-68.62%-11.53M

-47.68%-16.28M

38.30%-6.2M

-14.28%-30.68M

29.80%-2.77M

-220.20%-6.84M

11.98%-11.03M

37.44%-10.05M

62.19%-26.85M

76.97%-3.94M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-68.62%-11.53M	-47.68%-16.28M	38.30%-6.2M	-14.69%-30.68M	29.80%-2.77M	-219.39%-6.84M	11.58%-11.03M	37.44%-10.05M	62.27%-26.75M	76.96%-3.94M
Net income from continuing operations	540.65%23.04M	1,301.79%98.46M	-1,118.38%-121.29M	24.28%-31.54M	16.75%-8.17M	-263.78%-5.23M	36.91%-8.19M	54.85%-9.96M	50.63%-41.66M	48.89%-9.81M
Operating gains losses	-34,825.00%-34.93M	-69,425.00%-27.73M	-33.33%120K	-87.65%720K	--600K	---100K	--40K	--180K	--5.83M	----
Depreciation and amortization	-17.07%34K	-19.51%33K	3.03%34K	-4.82%158K	22.86%43K	20.59%41K	36.67%41K	-50.75%33K	-89.98%166K	-88.14%35K
Deferred tax	-275.00%-14K	0.00%7K	-12.50%7K	-50.00%14K	-212.50%-9K	60.00%8K	16.67%7K	-11.11%8K	27.27%28K	144.44%8K
Other non cash items	--0	-24,799.43%-86.2M	32,917.43%115.56M	31.61%1.83M	--0	218.93%1.13M	3.87%349K	0.00%350K	74.94%1.39M	0.00%349K
Change In working capital	58.59%-1.51M	68.15%-1.33M	17.07%-1.26M	-15,300.00%-9.24M	144.04%85K	-358.09%-3.64M	-173.34%-4.16M	-719.11%-1.52M	-102.11%-60K	54.16%-193K
-Change in receivables	35.41%-965K	-99.75%2K	-90.49%101K	-38.09%1.78M	331.74%1.4M	-378.73%-1.49M	52.82%813K	-56.06%1.06M	795.65%2.88M	31.79%-605K
-Change in inventory	--0	--0	--0	11.11%20K	--0	1,700.00%18K	-50.00%1K	-92.31%1K	151.43%18K	109.09%2K
-Change in prepaid assets	-518.46%-816K	-392.28%-1.44M	54.30%-154K	-58.69%447K	156.40%97K	-74.58%195K	-38.27%492K	-8.71%-337K	277.00%1.08M	82.18%-172K
-Change in payables and accrued expense	112.42%301K	102.47%136K	47.65%-1.18M	-178.81%-11.48M	-237.49%-1.3M	-648.15%-2.42M	-93.46%-5.5M	-18.90%-2.26M	-201.80%-4.12M	111.38%947K
-Change in other current liabilities	463.64%80K	247.06%25K	-1,330.77%-186K	-744.44%-76K	-118.18%-24K	-83.33%-22K	-54.55%-17K	-152.00%-13K	80.00%-9K	-320.00%-11K
-Change in other working capital	----	-206.25%-51K	618.18%158K	-20.45%70K	75.14%-88K	--88K	--48K	--22K	--88K	---354K
Cash from discontinued investing activities
Operating cash flow	-68.62%-11.53M	-47.68%-16.28M	38.30%-6.2M	-14.69%-30.68M	29.80%-2.77M	-219.39%-6.84M	11.58%-11.03M	37.44%-10.05M	62.27%-26.75M	76.96%-3.94M
Investing cash flow
Cash flow from continuing investing activities	0	0	367.67%356K	-40.00%-133K	0	0	0	-133K	15.93%-95K	0
Net PPE purchase and sale	--0	--0	--0	126.32%25K	--0	--0	--0	--25K	15.93%-95K	--0
Net business purchase and sale	--0	--0	--356K	----	----	--0	--0	--0	----	----
Net other investing changes	----	----	----	---158K	--0	--0	--0	---158K	----	----
Cash from discontinued investing activities
Investing cash flow	--0	--0	367.67%356K	-40.00%-133K	--0	--0	--0	---133K	15.93%-95K	--0
Financing cash flow
Cash flow from continuing financing activities	0	-178.93%-472K	690.02%108.61M	270.37%25.04M	-98.78%1K	10.7M	104.05%598K	13.75M	-113.77%-14.7M	7.89%82K
Net issuance payments of debt	--0	----	----	---21.24M	--0	---15.24M	----	----	--0	--14.81M
Net common stock issuance	--0	--0	741.03%115.63M	412.88%46.22M	100.01%1K	--25.94M	--6.53M	--13.75M	-120.54%-14.77M	-17,914.63%-14.77M
Proceeds from stock option exercised by employees	--0	----	----	-8.22%67K	--0	--0	----	----	-96.22%73K	-69.62%48K
Net other financing activities	--0	---472K	---7.01M	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	-178.93%-472K	690.02%108.61M	270.37%25.04M	-98.78%1K	--10.7M	104.05%598K	--13.75M	-113.77%-14.7M	7.89%82K
Net cash flow
Beginning cash position	1,349.82%93.56M	553.47%110.31M	-43.34%7.55M	-75.72%13.32M	-39.97%10.31M	-43.84%6.45M	-56.49%16.88M	-75.72%13.32M	187.15%54.86M	-76.11%17.18M
Current changes in cash	-398.70%-11.53M	-60.67%-16.76M	2,784.25%102.77M	86.11%-5.77M	28.33%-2.77M	-32.14%3.86M	61.81%-10.43M	122.18%3.56M	-216.19%-41.55M	77.35%-3.86M
End cash Position	695.48%82.03M	1,349.82%93.56M	553.47%110.31M	-43.33%7.55M	-43.33%7.55M	-39.97%10.31M	-43.84%6.45M	-56.49%16.88M	-75.72%13.32M	-75.72%13.32M
Free cash flow	-68.62%-11.53M	-47.68%-16.28M	38.30%-6.2M	-14.28%-30.68M	29.80%-2.77M	-220.20%-6.84M	11.98%-11.03M	37.44%-10.05M	62.19%-26.85M	76.97%-3.94M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data